229 related articles for article (PubMed ID: 11012175)
1. IL-3 does not contribute to platelet production in c-Mpl-deficient mice.
Chen Q; Solar G; Eaton DL; de Sauvage FJ
Stem Cells; 1998; 16 Suppl 2():31-6. PubMed ID: 11012175
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
Murone M; Carpenter DA; de Sauvage FJ
Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
[TBL] [Abstract][Full Text] [Related]
3. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
[TBL] [Abstract][Full Text] [Related]
4. Dissection of c-Mpl and thrombopoietin function: studies of knockout mice and receptor signal transduction.
Gurney AL; de Sauvage FJ
Stem Cells; 1996; 14 Suppl 1():116-23. PubMed ID: 11012211
[TBL] [Abstract][Full Text] [Related]
5. The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels.
Geddis AE; Fox NE; Kaushansky K
Exp Hematol; 2006 Jan; 34(1):82-6. PubMed ID: 16413394
[TBL] [Abstract][Full Text] [Related]
6. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice.
Carver-Moore K; Broxmeyer HE; Luoh SM; Cooper S; Peng J; Burstein SA; Moore MW; de Sauvage FJ
Blood; 1996 Aug; 88(3):803-8. PubMed ID: 8704234
[TBL] [Abstract][Full Text] [Related]
7. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor.
Gainsford T; Nandurkar H; Metcalf D; Robb L; Begley CG; Alexander WS
Blood; 2000 Jan; 95(2):528-34. PubMed ID: 10627458
[TBL] [Abstract][Full Text] [Related]
8. c-mpl, the thrombopoietin receptor.
Vainchenker W; Methia N; Debili N; Titeux M; Wendling F
Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
[TBL] [Abstract][Full Text] [Related]
9. A possible role for thrombopoietin and its receptor c-mpl in the pathobiology of essential thrombocythemia.
Griesshammer M; Bangerter M; Schrezenmeier H
Semin Thromb Hemost; 1997; 23(5):419-23. PubMed ID: 9387200
[TBL] [Abstract][Full Text] [Related]
10. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets.
Li J; Sabath DF; Kuter DJ
Cytokine; 2000 Jul; 12(7):835-44. PubMed ID: 10880227
[TBL] [Abstract][Full Text] [Related]
11. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M
Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548
[TBL] [Abstract][Full Text] [Related]
12. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin.
Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ
Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025
[TBL] [Abstract][Full Text] [Related]
13. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia.
Li J; Xia Y; Kuter DJ
Br J Haematol; 2000 Dec; 111(3):943-53. PubMed ID: 11122159
[TBL] [Abstract][Full Text] [Related]
14. Mpl: from an acute myeloproliferative virus to the isolation of the long sought thrombopoietin.
Souyri M
Semin Hematol; 1998 Jul; 35(3):222-31. PubMed ID: 9685168
[TBL] [Abstract][Full Text] [Related]
15. Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling.
Carpinelli MR; Hilton DJ; Metcalf D; Antonchuk JL; Hyland CD; Mifsud SL; Di Rago L; Hilton AA; Willson TA; Roberts AW; Ramsay RG; Nicola NA; Alexander WS
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6553-8. PubMed ID: 15071178
[TBL] [Abstract][Full Text] [Related]
16. Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production.
Gainsford T; Roberts AW; Kimura S; Metcalf D; Dranoff G; Mulligan RC; Begley CG; Robb L; Alexander WS
Blood; 1998 Apr; 91(8):2745-52. PubMed ID: 9531584
[TBL] [Abstract][Full Text] [Related]
17. Platelets exposed to elevated levels of endogenous thrombopoietin in vivo have a reduced response to megakaryocyte growth and development factor in vitro.
Nishiyama U; Morita H; Torii Y; Kuwaki T; Shimizu E; Akahori H; Kato T; Miyazaki H
Thromb Haemost; 2001 Jan; 85(1):152-9. PubMed ID: 11204567
[TBL] [Abstract][Full Text] [Related]
18. [Expression of thrombopoietin related genes in patients with idiopathic thrombocytopenic purpura].
Zhang X; Yang Y; Shi H
Zhonghua Xue Ye Xue Za Zhi; 1998 Nov; 19(11):587-9. PubMed ID: 11263344
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin in vitro and in vivo.
Alexander WS; Begley CG
Cytokines Cell Mol Ther; 1998 Mar; 4(1):25-34. PubMed ID: 9557214
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoietin: the primary regulator of megakaryocyte and platelet production.
Kaushansky K
Thromb Haemost; 1995 Jul; 74(1):521-5. PubMed ID: 8578518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
